title: Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1.
abstract: C-terminal binding protein 1 (CtBP1) is a transcriptional co-repressor and metabolic sensory protein, which often represses tumor suppressor genes. Hence, we sought to determine if CtBP1 affects expression of the tumor suppressor Brca1 in head and neck tissue, as downregulation of Brca1 begins at the early stages of head and neck squamous cell carcinomas (HNSCCs). We found that CtBP1 represses Brca1 transcription by binding to the E2F4 site of the Brca1 promoter. Additionally, the recruitment of CtBP1 to the Brca1 promoter is redox-dependent, that is, increased at high NADH levels in hypoxic conditions. Further, immunostaining using a human HNSCC tissue array revealed that nuclear CtBP1 staining began to accumulate in hyperplasic lesions and HNSCCs, this staining correlated with Brca1 downregulation in these lesions. Pharmacological disruption of CtBP1 binding to Brca1 promoter by the antioxidant Tempol, which reduces NADH levels, relieved CtBP1-mediated repression of Brca1, leading to increased DNA repair in HNSCC cells. As tumor cells are generally hypoxic with increased NADH levels, the dynamic control of Brca1 by a 'metabolic switch' found in this study not only provides an important link between tumor metabolism and tumor suppressor expression but also suggests a potential chemo preventative or therapeutic strategy for HNSCC by blocking NADH-dependent CtBP1 activity at early stages of HNSCC carcinogenesis.
authors.affiliation: Department of Dermatology, University of Colorado, Denver, Aurora, CO 80045, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Deng
authors.forename: J
authors.initials: J
authors.lastname: Liu
authors.forename: G
authors.initials: G
authors.lastname: Han
authors.forename: S-L
authors.initials: SL
authors.lastname: Lu
authors.forename: S-Y
authors.initials: SY
authors.lastname: Wang
authors.forename: S
authors.initials: S
authors.lastname: Malkoski
authors.forename: A C
authors.initials: AC
authors.lastname: Tan
authors.forename: C
authors.initials: C
authors.lastname: Deng
authors.forename: X-J
authors.initials: XJ
authors.lastname: Wang
authors.forename: Q
authors.initials: Q
authors.lastname: Zhang
mesh_terms: D000429:Alcohol Oxidoreductases / Q000378:metabolism*; D019313:BRCA1 Protein / Q000235:genetics*; D002294:Carcinoma, Squamous Cell / Q000235:genetics*; D003497:Cyclic N-Oxides / Q000494:pharmacology; D004260:DNA Repair / Q000187:drug effects; D004268:DNA-Binding Proteins / Q000378:metabolism*; D015536:Down-Regulation; D050704:E2F4 Transcription Factor / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic; D006258:Head and Neck Neoplasms / Q000235:genetics*; D006801:Humans; D009243:NAD / Q000378:metabolism*; D010084:Oxidation-Reduction; D011401:Promoter Regions, Genetic / Q000187:drug effects; D013113:Spin Labels; D014158:Transcription, Genetic
chemical_list: D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D003497:Cyclic N-Oxides; D004268:DNA-Binding Proteins; D050704:E2F4 Transcription Factor; C493762:E2F4 protein, human; D013113:Spin Labels; D009243:NAD; D000429:Alcohol Oxidoreductases; C096794:C-terminal binding protein; C001803:tempol
references.citation: Cancer Res. 2009 Feb 1;69(3):731-4
references.pmid: 19155295
references.citation: Cancer Res. 2008 Mar 1;68(5):1601-8
references.pmid: 18316625
references.citation: Oncogene. 1989 Apr;4(4):415-20
references.pmid: 2524023
references.citation: Oncogene. 2000 Aug 3;19(33):3823-8
references.pmid: 10949939
references.citation: Biochem J. 1967 May;103(2):514-27
references.pmid: 4291787
references.citation: Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5537-41
references.pmid: 1319064
references.citation: Cancer Biol Ther. 2006 Oct;5(10):1400-7
references.pmid: 17106239
references.citation: Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9574-9
references.pmid: 10449734
references.citation: Mol Cell. 2002 Feb;9(2):213-24
references.pmid: 11864595
references.citation: J Clin Invest. 2009 Nov;119(11):3408-19
references.pmid: 19841536
references.citation: Oncogene. 1998 Dec 17;17(24):3115-24
references.pmid: 9872327
references.citation: Cancer Res. 2010 Jan 15;70(2):532-42
references.pmid: 20068145
references.citation: Oncogene. 2004 Jan 29;23(4):1000-4
references.pmid: 14647419
references.citation: J Biol Chem. 1999 Mar 26;274(13):8837-43
references.pmid: 10085126
references.citation: ORL J Otorhinolaryngol Relat Spec. 2007;69(4):218-25
references.pmid: 17409780
references.citation: Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10467-71
references.pmid: 7479821
references.citation: J Biol Chem. 2003 May 16;278(20):17876-84
references.pmid: 12637547
references.citation: Nat Struct Biol. 2003 Aug;10(8):622-8
references.pmid: 12872159
references.citation: Nat Rev Cancer. 2003 Jan;3(1):23-34
references.pmid: 12509764
references.citation: Cell. 2003 Oct 17;115(2):177-86
references.pmid: 14567915
references.citation: Biochim Biophys Acta. 1990 Jun 20;1034(3):285-9
references.pmid: 2114173
references.citation: Cell Death Differ. 2009 Apr;16(4):584-92
references.pmid: 19136938
references.citation: Science. 2002 Mar 8;295(5561):1895-7
references.pmid: 11847309
references.citation: Cancer Res. 2005 Dec 15;65(24):11597-604
references.pmid: 16357170
references.citation: N Engl J Med. 2001 Dec 27;345(26):1890-900
references.pmid: 11756581
references.citation: Hum Mol Genet. 2005 Jun 15;14(12):1699-708
references.pmid: 15888486
references.citation: Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9029-33
references.pmid: 16740659
references.citation: JAMA. 2007 Jan 10;297(2):187-95
references.pmid: 17213402
references.citation: Oncogene. 1998 Apr 30;16(17):2229-41
references.pmid: 9619832
references.citation: EMBO J. 1993 Feb;12(2):469-78
references.pmid: 8440238
references.citation: Clin Cancer Res. 2004 Oct 1;10(19):6411-7
references.pmid: 15475427
references.citation: Oncogene. 2003 Aug 21;22(35):5415-26
references.pmid: 12934101
references.citation: Hum Mol Genet. 2004 Aug 15;13(16):1793-802
references.pmid: 15213104
references.citation: Arch Otolaryngol Head Neck Surg. 2003 Jan;129(1):106-12
references.pmid: 12525204
references.citation: Nat Struct Mol Biol. 2005 May;12(5):423-8
references.pmid: 15834423
references.citation: Curr Biol. 2003 Jul 15;13(14):1234-9
references.pmid: 12867035
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):829-33
references.pmid: 17213307
references.citation: Laryngoscope. 2006 May;116(5):735-41
references.pmid: 16652080
references.citation: Free Radic Biol Med. 2003 Jan 1;34(1):93-102
references.pmid: 12498984
references.citation: Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9202-7
references.pmid: 12872005
references.citation: Breast Cancer Res. 2003;5(1):45-52
references.pmid: 12559046
references.citation: Oncogene. 2001 Oct 25;20(48):7110-4
references.pmid: 11704836
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 Oct;293(4):L952-9
references.pmid: 17693484
references.citation: Nat Rev Cancer. 2005 Feb;5(2):127-35
references.pmid: 15685196